https://biotechmorning.com/news/genmab-ovarian-cancer-adc-wont-quit Biotech Morning en 2026-10-04T14:12:52.114Z The Ovarian Cancer Drug That Won't Quit https://biotechmorning.com/news/zepbound-cheaper-vials-pricing Biotech Morning en 2026-10-04T14:12:06.387Z Zepbound Just Got a Price Tag That Changes Everything https://biotechmorning.com/news/cutaneous-lupus-litifilimab-52-week-data Biotech Morning en 2026-10-04T14:11:22.794Z The Skin Disease With Zero Approved Drugs Just Got a Contender https://biotechmorning.com/news/gsk-hutchmed-kras-deal Biotech Morning en 2026-10-04T14:10:41.415Z GSK Just Paid $110M for a Drug That Hasn't Treated a Single Patient Yet https://biotechmorning.com/news/lilly-ajax-therapeutics-jak-inhibitor-acquisition Biotech Morning en 2026-10-04T14:09:56.578Z Lilly Just Dropped $2.3 Billion on a Drug Class Everyone Gave Up On https://biotechmorning.com/news/genmab-8-billion-merus-acquisition Biotech Morning en 2026-10-04T14:09:10.715Z Genmab Just Wrote an $8 Billion Check for One Cancer Drug https://biotechmorning.com/news/shanghai-biotech-city-courting-western-pharma Biotech Morning en 2026-10-04T14:08:24.300Z Shanghai Built a Biotech City. Now It Wants Your Pipeline. https://biotechmorning.com/news/china-crashed-obesity-drug-party Biotech Morning en 2026-10-04T14:07:40.520Z China Just Crashed the Obesity Drug Party https://biotechmorning.com/news/fda-cder-office-china-clinical-trial-race Biotech Morning en 2026-10-04T14:06:52.606Z The FDA Just Declared a Space Race Against China https://biotechmorning.com/news/pirtobrutinib-frontline-cll-approval Biotech Morning en 2026-10-03T14:15:15.837Z The Blood Cancer Drug That Skipped the Line https://biotechmorning.com/news/merck-kgaa-bio-techne-acquisition-2 Biotech Morning en 2026-10-03T14:14:29.658Z Merck KGaA Just Made Its Biggest Bet in a Decade. It's on Lab Supplies. https://biotechmorning.com/news/xaira-ai-antibody-design-platform Biotech Morning en 2026-10-03T14:13:46.744Z The Billion-Dollar Bet That AI Can Skip the Hardest Part of Drug Design https://biotechmorning.com/news/florida-sues-pfizer-covid-vaccine Biotech Morning en 2026-10-03T14:13:03.682Z Florida Just Sued the World's Biggest Vaccine Maker. It's Personal. https://biotechmorning.com/news/heart-valve-grows-with-kid Biotech Morning en 2026-10-03T14:12:22.707Z The Heart Valve That Grows Up With Your Kid https://biotechmorning.com/news/rna-activation-ractigen-dmd-first-in-human Biotech Morning en 2026-10-03T14:11:41.665Z The RNA Trick Nobody Thought Would Work Just Worked in Humans https://biotechmorning.com/news/bayer-2-2-billion-ohio-pharma-manufacturing Biotech Morning en 2026-10-03T14:10:50.717Z Bayer Just Bet $2.2 Billion That Ohio Is the Future of Pharma https://biotechmorning.com/news/generate-biomedicines-400-million-ipo Biotech Morning en 2026-10-03T14:10:06.769Z A Robot Just Raised $400 Million on Wall Street https://biotechmorning.com/news/adarx-446-million-ipo-rna-therapeutics Biotech Morning en 2026-10-03T14:09:24.156Z A $446 Million Bet That RNA Drugs Can Go Anywhere in the Body https://biotechmorning.com/news/regeneron-trevogrumab-muscle-loss-semaglutide Biotech Morning en 2026-10-03T14:08:34.592Z Regeneron's Answer to the Biggest Problem With Ozempic